PrecISE, the Precision Interventions for Severe and/or Exacerbation-Prone Asthma Network, is a research study to understand how to treat different types of severe asthma. We are looking for people who have asthma attacks or frequent asthma symptoms. Everyone in the study will receive one or more study medicines for their severe asthma. This study is sponsored by the U.S. National Heart, Lung, and Blood Institute (NHLBI). This study is designed to investigate new treatments for asthma that are thought to work better in some patients than in others.
This 6 month-long study aims to raise awareness of COVID-19 among Arizona populations disproportionately affected by the virus; Latino, American Indian, and African American communities. If you choose to participate, you will be asked to complete study questionnaires and receive information regarding prevention and treatment of COVID-19 by phone, handouts, text, or social media as well as be provided information regarding prevention and treatment trials that are available for COVID-19.
No study has been performed to prospectively record the presenting complaints, signs, symptoms and comorbidities of children who raised the suspicion of pulmonary embolism (PE). Clinicians must extrapolate what is known about PE in adults to children. Perhaps as a result, the mortality rate of PE is the same in children as it is in adults. On the other hand, tens of thousands of low risk children and adolescents are unnecessarily exposed to increased lifetime cancer risk from ionizing radiation from CT scans done to search for PE they do not have.
We will hold individual interviews of HLBS patients, including a range of racial, ethnic, and socioeconomic perspectives, to discuss current and future Artificial Intelligence/Big Data technologies. Participants will be recruited from University of Arizona affiliated clinical practices or online, offering $25 each for participation in 60-minute discussions, either by phone or video conference
The Oral Bacterial Extract (ORBEX) Study is a three year study to see whether the wheezing and lower respiratory tract illnesses that lead to asthma can be prevented. The goal is to find if a medication that is used in Europe, called Broncho-Vaxom®, can prevent wheezing lower respiratory infections in young children. It may work to stimulate a child’s immune system in order to increase the body’s defenses against germs that cause children to have respiratory illnesses.
We are looking for overweight individuals who have asthma and want to start working out regularly. Researchers believe that exercise may have a beneficial effect on inflammation and asthma symptoms in overweight people with mild to moderate persistent asthma. The purpose of this study is to see if a 12-week exercise program will affect inflammation, lung function, asthma symptoms, and asthma quality of life in overweight adults with asthma.
The Pediatric Acute Respiratory Distress Syndrome Incidence and Epidemiology (PARDIE) study is designed as a multi-center international observational, cross sectional study of new cases of PARDS involving 5 continuous days of screening and patient enrollment, occurring every 2 months for a year (6 total study weeks). Included patients will have a new diagnosis of PARDS during the study week or be at risk for PARDS. Data collection will concentrate on the first 3 days of PARDS diagnosis, and follow outcomes such as mortality and length of ventilation.